# Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT

> **NCT00564174** · NA · TERMINATED · sponsor: **Mount Sinai Hospital, Canada** · enrollment: 88 (actual)

## Conditions studied

- Recurrent Pregnancy Loss
- Antiphospholipid Antibody Syndrome

## Interventions

- **DRUG:** Low molecular weight heparin and low dose aspirin
- **DRUG:** Low dose aspirin

## Key facts

- **NCT ID:** NCT00564174
- **Lead sponsor:** Mount Sinai Hospital, Canada
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-03
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 88 (ACTUAL)
- **Why stopped:** interim analysis found no difference in LB rate and lower than expected event rate
- **Last updated:** 2007-11-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00564174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00564174, "Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00564174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*